相关实验视频

Updated: May 5, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K

ctDNA清除预测了不可切除的EGFR突变NSCLC的存活率:一个元分析

Peixian Li1, Yujiao Zhang1, Fangyuan Qin1

  • 1Department of Oncology, Heilongjiang Beidahuang Group General Hospital, Harbin, Heilongjiang, China.

Frontiers in oncology
|March 4, 2026
PubMed
概括

在表皮生长因子受体氨酸激酶抑制剂 (EGFR-TKI) 治疗期间,循环瘤DNA (ctDNA) 的清除与非小细胞肺癌 (NSCLC) 的更好的生存率有关. 这种非侵入性生物标志物显示出预后潜力.

关键词:
发生EGFR突变的原因ctDNA 清除时间这是一个元分析.非小细胞肺癌的肺癌.预后生物标志物 预后生物标志物

更多相关视频

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

15.0K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870